March 29, 2023

Dubai Week

Complete Dubai News World

European stocks fell from record highs after gaining eight sessions

Highs on optimism about the effectiveness of the vaccine in preventing Wall Street omigran

© Reuters. Traders during trading on the New York Stock Exchange on Wednesday. Photo: Brendan McDermott / Reuters.

NEW YORK (Reuters) – Wall Street closed slightly higher on Wednesday as investors cheered on encouraging news about Pfizer and its partner Beyonc’s COVID-19.

Both companies were able to neutralize the new strain of Omigron in a laboratory test of their vaccine’s three-dose approach, and may offer a vaccine developed in March 2022 if needed.

Three major indices of US stocks ended higher. Also the airline stock index touched its highest level since November 24, which was recorded even before the news of the new mutation.

According to preliminary data, the benchmark Standard & Poor’s 500 Index traded up 14.56 points, or 0.31 percent, at 4,701.31 points, while the Nasdaq index rose 99.33 points, or 0.63 percent, to 15,7.86 points.

The industry index ended 33.74 points, or 0.09 percent, higher at 35,753.17 points.

(Produced by Waqti Al-Alfi for the Arabic Bulletin)

Explanation of risks: Fusion Media I would like to remind you that the data on this website is not real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges but by market makers, so prices may be inaccurate and may differ from the actual market price, i.e. for marking and trading purposes only. Therefore Fusion Media will not be liable for any business losses incurred by you for using this data.

Fusion Media Or anyone associated with Fusion Media will not be liable for any loss or damage resulting from reliance on the information contained in this website, including data, quotes, charts and buy / sell signals. Be fully informed about the risks and costs associated with trading financial markets, which is one of the most potentially risky investment forms.

See also  Canada was the first country to announce full approval for the "Johnson & Johnson" vaccine against "Corona".